146 related articles for article (PubMed ID: 34399808)
1. Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers.
Reinisch M; Kuemmel S; Breit E; Theuerkauf I; Harrach H; Schindowski D; Moka D; Bettstetter M; Bruzas S; Chiari O
Orphanet J Rare Dis; 2021 Aug; 16(1):363. PubMed ID: 34399808
[TBL] [Abstract][Full Text] [Related]
2. Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing.
Lei T; Shen M; Deng X; Shi Y; Peng Y; Wang H; Chen T
Orphanet J Rare Dis; 2022 Oct; 17(1):382. PubMed ID: 36271373
[TBL] [Abstract][Full Text] [Related]
3. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
[TBL] [Abstract][Full Text] [Related]
5. Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
Cani AK; Hovelson DH; McDaniel AS; Sadis S; Haller MJ; Yadati V; Amin AM; Bratley J; Bandla S; Williams PD; Rhodes K; Liu CJ; Quist MJ; Rhodes DR; Grasso CS; Kleer CG; Tomlins SA
Mol Cancer Res; 2015 Apr; 13(4):613-9. PubMed ID: 25593300
[TBL] [Abstract][Full Text] [Related]
6. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
Gatalica Z; Vranic S; Ghazalpour A; Xiu J; Ocal IT; McGill J; Bender RP; Discianno E; Schlum A; Sanati S; Palazzo J; Reddy S; Pockaj B
Oncotarget; 2016 Jan; 7(2):1707-16. PubMed ID: 26625196
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mutation profile between primary phyllodes tumors of the breast and their paired local recurrences.
Mitus J; Adamczyk A; Majchrzyk K; Kowalik A; Ryś J; Niemiec J
Pol J Pathol; 2020; 71(1):7-12. PubMed ID: 32429649
[TBL] [Abstract][Full Text] [Related]
8. MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Laé M; Gardrat S; Rondeau S; Richardot C; Caly M; Chemlali W; Vacher S; Couturier J; Mariani O; Terrier P; Bièche I
Oncotarget; 2016 Dec; 7(51):84428-84438. PubMed ID: 27806318
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
Jones AM; Mitter R; Springall R; Graham T; Winter E; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Apr; 214(5):533-44. PubMed ID: 18288784
[TBL] [Abstract][Full Text] [Related]
10. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic profiling of malignant phyllodes tumors of the breast.
Nozad S; Sheehan CE; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Schrock AB; Hirshfield KM; Ali N; Ganesan S; Ali SM; Miller VA; Stephens PJ; Ross JS; Chung JH
Breast Cancer Res Treat; 2017 Apr; 162(3):597-602. PubMed ID: 28210881
[TBL] [Abstract][Full Text] [Related]
12. Genomic landscapes of breast fibroepithelial tumors.
Tan J; Ong CK; Lim WK; Ng CC; Thike AA; Ng LM; Rajasegaran V; Myint SS; Nagarajan S; Thangaraju S; Dey S; Nasir ND; Wijaya GC; Lim JQ; Huang D; Li Z; Wong BH; Chan JY; McPherson JR; Cutcutache I; Poore G; Tay ST; Tan WJ; Putti TC; Ahmad BS; Iau P; Chan CW; Tang AP; Yong WS; Madhukumar P; Ho GH; Tan VK; Wong CY; Hartman M; Ong KW; Tan BK; Rozen SG; Tan P; Tan PH; Teh BT
Nat Genet; 2015 Nov; 47(11):1341-5. PubMed ID: 26437033
[TBL] [Abstract][Full Text] [Related]
13. MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
Garcia-Dios DA; Levi D; Shah V; Gillett C; Simpson MA; Hanby A; Tomlinson I; Sawyer EJ
Br J Cancer; 2018 Jan; 118(2):277-284. PubMed ID: 29315289
[TBL] [Abstract][Full Text] [Related]
14. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.
Lim SZ; Ng CCY; Rajasegaran V; Guan P; Selvarajan S; Thike AA; Nasir NDBM; Koh VCY; Tan BKT; Ong KW; Teh BT; Tan PH
Breast Cancer Res Treat; 2019 Apr; 174(2):365-373. PubMed ID: 30511242
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.
Geyer FC; Burke KA; Piscuoglio S; Ng CKY; Papanastasiou AD; Marchiò C; Selenica P; Edelweiss M; Murray MP; Brogi E; Soslow RA; Rubin BP; Norton L; Reis-Filho JS; Weigelt B
Mol Oncol; 2017 Aug; 11(8):913-926. PubMed ID: 28267263
[TBL] [Abstract][Full Text] [Related]
16. MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
Piscuoglio S; Murray M; Fusco N; Marchiò C; Loo FL; Martelotto LG; Schultheis AM; Akram M; Weigelt B; Brogi E; Reis-Filho JS
Histopathology; 2015 Nov; 67(5):719-29. PubMed ID: 25855048
[TBL] [Abstract][Full Text] [Related]
17. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract][Full Text] [Related]
18. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast.
Kim JY; Yu JH; Nam SJ; Kim SW; Lee SK; Park WY; Noh DY; Nam DH; Park YH; Han W; Lee JE
Transl Oncol; 2018 Feb; 11(1):18-23. PubMed ID: 29145046
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome profiling helps to classify phyllodes tumours of the breast.
Laé M; La Rosa P; Mandel J; Reyal F; Hupé P; Terrier P; Couturier J
J Clin Pathol; 2016 Dec; 69(12):1081-1087. PubMed ID: 27207013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
